Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

NSE:BIOFILCHEM Revenue

In the fiscal year ending March 31, 2025, Biofil Chemicals and Pharmaceuticals had annual revenue of 334.02M INR, down -17.34%. Biofil Chemicals and Pharmaceuticals had revenue of 83.51M in the quarter ending March 31, 2025, a decrease of -46.39%.

• Revenue: 334.02M
• Revenue Growth: -17.34%
• P/S Ratio: 2.27
• Revenue / Employee: 12.85M
• Employees: 26
• Market Cap: 757.06M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	334.02M	-70.07M	-17.34%
Mar 31, 2024	404.09M	103.74M	34.54%
Mar 31, 2023	300.35M	76.53M	34.19%
Mar 31, 2022	223.82M	-134.27M	-37.50%
Mar 31, 2021	358.10M	60.42M	20.30%